HOUSTON–(BUSINESS WIRE)–Emerging Healthcare Solutions, Inc. (Pink Sheets:EHSI) disclosed today that their first comprehensive medical iPhone Application module named MedAnywhere HHC has entered the final phase of development. MedAnywhere is an iPhone application that contains several modules that are designed to reduce patient costs and allow direct physician monitoring. The MedAnywhere HHC module is scheduled for submission to iTunes by mid-September. VITEB is EHSI’s development partner on the MedAnywhere projects.
HHC is the disease that occurs as a result of significant iron overload and it can have genetic or non-genetic causes. HHC can cause major damage to the heart, liver, pancreas, joints and pituitary. If the extra iron is not removed, these organs can become diseased. Untreated Hemochromatosis can be fatal. Traditionally, HHC treatment requires numerous costly visits to the lab for blood work and expensive phlebotomy treatments performed at hospitals. The MedAnywhere© HHC module is being configured to allow a customer’s Hematocrit levels to be monitored by a doctor via the iPhone. As a result, customers are able to be directed by their doctor to have phlebotomy treatments done at blood donor centers, which usually perform the treatment for no charge. The MedAnywhere© HHC module is designed to allow many patient/customers to realize savings of thousands or even tens of thousands of dollars as a result.
Emerging Healthcare Solutions is developing the MedAnywhere app and modules for use on Apple’s (NASDAQ: AAPL) iPhone prior to developing the project for Google’s (NASDAQ: GOOG) Android and Research in Motion’s (NASDAQ: RIMM) BlackBerry devices. Emerging Healthcare Solutions focuses on the development of profitable emerging medical technology, a sector that also includes Amgen (NASDAQ: AMGN).
About Emerging Healthcare Solutions, Inc.
Emerging Healthcare Solutions, Inc. is a medical technology company that works to bring new and innovative medical technologies to the market. The Company’s model is to engage a technology prior to its inflection point in order to maximize the profits available to EHSI as that new technology is adopted. Our common stock is traded under the symbol EHSI.
For more information, visit www.emerginghealthcaresolutionsinc.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Related News
FTC approves Google’s AdMob buy, cites Apple’s iAd competition
Google developing free navigation app?
Verizon Drafts Developers Into Mobile Software War on Apple
Palm Pre App Catalog Makes a Slow Start- CES Preview: TomTom App for iPhone/iPad Goes Social